You get the concentrations the published literature actually used: 1% GHK-Cu, paired with Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7
16 weeks ~20 syringes Pre-blend: 1/week
Given the large body of literature on GLP-1 mechanisms ranging from endocrinology to neuroscience and corresponding preclinical and clinical data, GLP-1-based treatment could offer a new pathway for treatment in diverse fields
This influences stability and handling in the laboratory, though both are typically supplied as lyophilized powders requiring reconstitution
Several previously recommended sources are no longer viable: Vendor Status What Happened Peptide Sciences Shut down Ceased operations in early 2026
Distinguishing sensory, liking, wanting, and homeostatic response patterns may therefore improve clinical communication, nutritional counselling, and individualised treatment planning, in line with obesity pharmacotherapy guidance emphasising the combination of medication with lifestyle and behavioural management (96)
